WO2004004631A3 - Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body - Google Patents

Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body Download PDF

Info

Publication number
WO2004004631A3
WO2004004631A3 PCT/IB2003/002678 IB0302678W WO2004004631A3 WO 2004004631 A3 WO2004004631 A3 WO 2004004631A3 IB 0302678 W IB0302678 W IB 0302678W WO 2004004631 A3 WO2004004631 A3 WO 2004004631A3
Authority
WO
WIPO (PCT)
Prior art keywords
infections
synthetical
treatment
respiratory system
upper respiratory
Prior art date
Application number
PCT/IB2003/002678
Other languages
French (fr)
Other versions
WO2004004631A2 (en
Inventor
Abdo Saeed Ahmed Shifa
Original Assignee
Abdo Saeed Ahmed Shifa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdo Saeed Ahmed Shifa filed Critical Abdo Saeed Ahmed Shifa
Priority to AU2003281259A priority Critical patent/AU2003281259A1/en
Priority to CA002488384A priority patent/CA2488384A1/en
Priority to EP03740883A priority patent/EP1519739A2/en
Publication of WO2004004631A2 publication Critical patent/WO2004004631A2/en
Publication of WO2004004631A3 publication Critical patent/WO2004004631A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/241—Lead; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This is a 100% herbal medicine completely free from synthetical chemicals. It is considered an alternative for the common antibiotics based on synthetical compounds that are used for the treatment of the upper respiratory system infections. This invention is a greenish-brown semi solid mixture of herbs provided in an acidic media. It is an oral syrup drug taken through mouth. This medicine was proved effective on both viral and bacterial infections unlike synthetical antibiotics that deal with bacterial infections only. This medicine is different from other herbal drugs as it cures the causes and not only the symptomes of the disease in a limited period of time extending from 3-7 days. It gives energy and strength to the human body as it raises the level of immunity.
PCT/IB2003/002678 2002-07-09 2003-07-04 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body WO2004004631A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003281259A AU2003281259A1 (en) 2002-07-09 2003-07-04 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body
CA002488384A CA2488384A1 (en) 2002-07-09 2003-07-04 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body
EP03740883A EP1519739A2 (en) 2002-07-09 2003-07-04 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EG2002070791 2002-07-09
EG2002070791 2002-07-09
AE186/2003 2003-06-15
AE18603 2003-06-15

Publications (2)

Publication Number Publication Date
WO2004004631A2 WO2004004631A2 (en) 2004-01-15
WO2004004631A3 true WO2004004631A3 (en) 2004-03-11

Family

ID=31979083

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/002678 WO2004004631A2 (en) 2002-07-09 2003-07-04 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body

Country Status (5)

Country Link
EP (1) EP1519739A2 (en)
AU (1) AU2003281259A1 (en)
CA (1) CA2488384A1 (en)
RU (1) RU2005103235A (en)
WO (1) WO2004004631A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932624B2 (en) 2007-06-20 2015-01-13 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9497975B2 (en) 2011-12-06 2016-11-22 The Trustees Of Columbia University In The City Of New York Broad spectrum natural preservative composition
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
AU2012332495B2 (en) 2011-11-03 2017-06-08 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
CN103432450A (en) * 2013-08-22 2013-12-11 岳冀 Preparation method for traditional Chinese medicine for treating swollen type acute cervical lymphadenitis
CN104524014A (en) * 2014-12-24 2015-04-22 胡文杰 Traditional Chinese medicine composition for treating primary dysmenorrhea with cold-damp stagnation
CN108434377A (en) * 2018-05-17 2018-08-24 重庆跃龙生物制药有限公司 Chinese medicine composition and preparation method thereof for treating gastrointestinal lymphoid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4012884A1 (en) * 1990-04-23 1991-10-24 Lichtwer Pharma Gmbh Garlic extracts contg. alliinase - have improved therapeutic activity for treating hypertension, arteriosclerosis, diarrhoea, intestinal worms etc.
WO1995005839A1 (en) * 1993-08-25 1995-03-02 Medenica Rajko D Nigella sativa as a medicinal treatment
RU2169575C1 (en) * 2000-05-24 2001-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Preparation for organism aging delay
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4012884A1 (en) * 1990-04-23 1991-10-24 Lichtwer Pharma Gmbh Garlic extracts contg. alliinase - have improved therapeutic activity for treating hypertension, arteriosclerosis, diarrhoea, intestinal worms etc.
WO1995005839A1 (en) * 1993-08-25 1995-03-02 Medenica Rajko D Nigella sativa as a medicinal treatment
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
RU2169575C1 (en) * 2000-05-24 2001-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Preparation for organism aging delay

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ELA A.: "Antimicrobial evaluation and chromatographic analysis of some essential and fixed oils", PHARMAZIE, vol. 51, no. 12, 1996, pages 993 - 994, XP001180691 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932624B2 (en) 2007-06-20 2015-01-13 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US9497975B2 (en) 2011-12-06 2016-11-22 The Trustees Of Columbia University In The City Of New York Broad spectrum natural preservative composition

Also Published As

Publication number Publication date
RU2005103235A (en) 2005-09-20
AU2003281259A1 (en) 2004-01-23
WO2004004631A2 (en) 2004-01-15
CA2488384A1 (en) 2004-01-15
EP1519739A2 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
WO2007070677A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
BR0008039A (en) Combinations of formoterol and a tiotropium salt
EA200701519A1 (en) LIVE ATTENUATED ROTAVIRAL VACCINE FOR ORAL ADMINISTRATION
DE60127379D1 (en) FUNCTIONAL COATING OF LINEZOLID MICROPHONES FOR TASTE MASKING AND ASSOCIATED ORAL DRUG PREPARATION
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
HUP0102489A2 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2004004631A3 (en) Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body
WO2005058935A3 (en) Aqueous suspensions of ciclesonide for nebulisation
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
WO2007116102A3 (en) Therapeutic composition and use
WO2021205026A3 (en) Pharmaceutical composition for treatment of enveloped dna or rna virus induced infections and disorders
CN103027952A (en) Traditional Chinese medicine sachet for preventing flu
CN104352588B (en) A kind of medicament treating allergic rhinitis
WO2004023979A3 (en) Mucus formulation for mucosal surfaces and uses thereof
PL335758A1 (en) Application bird's antibodies
WO2004096172A3 (en) Vector for oral administration
WO2002094173A3 (en) Tamper resistant oral dosage form
RS20090150A (en) Use of nifuroxazide in the form of a component of a combined drug therapy for treating diseases associated with helicobacter pylori and a curing method for eradicating a causative agent
WO2005020904A3 (en) Oral neurotherapeutic cefazolin compositions
CN103007151A (en) Traditional Chinese medicine scented sachet for preventing influenza
CN102846670A (en) Biological medicament for treating finger biting addiction
Montalto Update on treatment of influenza A and B with Tamiflu
RU2001134578A (en) A method for the treatment of chronic intestinal diseases associated with dysbiosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CH DE DZ FI GB ID RU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003740883

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2488384

Country of ref document: CA

Ref document number: 2003281259

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2005103235

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2003740883

Country of ref document: EP